Non-inferiority study of telaprevir dose reduction regimen on telaprevir with pegylated interferon and ribavirin therapy for treatment-naive patients with chronic hepatitis C genotype 1; prospective r...

Mise à jour : Il y a 4 ans
Référence :

Non-inferiority study of telaprevir dose reduction regimen on telaprevir with pegylated interferon and ribavirin therapy for treatment-naive patients with chronic hepatitis C genotype 1; prospective randomized controlled, multicenter trial